What's new in the management of adult bronchiectasis?
- PMID: 28491293
- PMCID: PMC5399954
- DOI: 10.12688/f1000research.10613.1
What's new in the management of adult bronchiectasis?
Abstract
Bronchiectasis is a heterogeneous, chronic condition with many aetiologies. It poses a significant burden on patients and healthcare practitioners and services. Clinical exacerbations often result in reduced quality of life, increased rate of lung function decline, increased hospitalisation, and mortality. Recent focus in respiratory research, guidelines, and future management options has improved this clinical field in evidence-based practice, but further work and phase III clinical trials are required. This article aims to summarise and explore advances in management strategies in recent years and highlight areas of research and future focus.
Keywords: Bronchiectasis; NCFB; Non-Cystic Fibrosis bronchiectasis.
Conflict of interest statement
Competing interests: The authors declare that they have no competing interests.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Similar articles
-
Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.Semin Respir Crit Care Med. 2015 Apr;36(2):267-86. doi: 10.1055/s-0035-1547346. Epub 2015 Mar 31. Semin Respir Crit Care Med. 2015. PMID: 25826593 Review.
-
Hot topics and current controversies in non-cystic fibrosis bronchiectasis.Breathe (Sheff). 2019 Dec;15(4):286-295. doi: 10.1183/20734735.0261-2019. Breathe (Sheff). 2019. PMID: 31803263 Free PMC article. Review.
-
Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.Appl Health Econ Health Policy. 2013 Jun;11(3):299-304. doi: 10.1007/s40258-013-0027-z. Appl Health Econ Health Policy. 2013. PMID: 23580074
-
Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.Pulm Pharmacol Ther. 2014 Oct;29(1):80-8. doi: 10.1016/j.pupt.2014.02.002. Epub 2014 Mar 1. Pulm Pharmacol Ther. 2014. PMID: 24594263
-
Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.Respiration. 2014;88(3):177-84. doi: 10.1159/000366000. Epub 2014 Aug 22. Respiration. 2014. PMID: 25171580 Review.
Cited by
-
Preoperative controlling nutritional status score (CONUT) predicts postoperative complications of patients with bronchiectasis after lung resections.Front Nutr. 2023 Jan 20;10:1000046. doi: 10.3389/fnut.2023.1000046. eCollection 2023. Front Nutr. 2023. PMID: 36742422 Free PMC article.
-
Prevalence of bronchiectasis in adults: a meta-analysis.BMC Public Health. 2024 Sep 30;24(1):2675. doi: 10.1186/s12889-024-19956-y. BMC Public Health. 2024. PMID: 39350110 Free PMC article.
-
Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.Biomed Res Int. 2018 Jun 19;2018:6057589. doi: 10.1155/2018/6057589. eCollection 2018. Biomed Res Int. 2018. PMID: 30018981 Free PMC article. Review.
-
A novel nomogram for predicting postoperative pneumonia risk in patients with localized bronchiectasis.Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251320471. doi: 10.1177/17534666251320471. Ther Adv Respir Dis. 2025. PMID: 39988984 Free PMC article.
-
Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.Respir Res. 2024 Jul 17;25(1):283. doi: 10.1186/s12931-024-02903-1. Respir Res. 2024. PMID: 39020401 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical